Canadian Psychiatric Association

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)

Guest Editorial
Modern Views of Autism

Eric Fombonne


In Review
Autism Spectrum Disorders: Early Detection, Intervention, Education, and Psychopharmacological Management

Susan E Bryson, Sally J Rogers, Eric Fombonne


Diagnosis and Epidemiology of Autism Spectrum Disorders
Lee Tidmarsh, Fred R Volkmar


Genetic and Neurodevelopmental Influences in Autistic Disorder
Rob Nicolson, Peter Szatmari


Original Research
Attitudes of Senior Psychiatry Residents Toward Persons with Intellectual Disabilities

Hélène Ouellette-Kuntz, Philip Burge, David B Henry, Elspeth A Bradley, Pierre Leichner


The Efficacy of 2 Different Dosages of Methylphenidate in Treating Adults With Attention-Deficit Hyperactivity Disorder

Rachelle Bouffard, Lily Hechtman,, Klaus Minde, Fiorella Iaboni-Kassab


Delirium in Hospital: an Underreported Event at Discharge

Louis T van Zyl, Paul R Davidson


Brief Communication
Removing Barriers to Treatment of First-Episode Psychotic Disorders

Derek J Scholten, Ashok K Malla, Ross MG Norman, Terry S McLean, Elizabeth M McIntosh, Chris L McDonald,, Michael Eliasziw, Kathy N Speechley


Book Reviews

Couple Therapy with Gay Men.
Reviewed by
Peter Moore, MD, FRCPC

What Forever Means After The Death of a Child.
Reviewed by
Philip Cheifetz, MD, FRCPC

Fighting for Mental Health: A Personal View.
Reviewed by
Paul Grof, MD, FRCPC

Understanding the Mind: The Nature and Power of the Mind. 2nd ed.
Reviewed by
Scott Bishop, PhD, CPysch Zindel Segal, PhD, CPsych

Letters to the Editor

Response of Catatonic Schizophrenia to Amisulpride: A Case Report

Medication Noncompliance Among Psychiatric Outpatients In Iran

Diogenes Syndrome in a Pair of Siblings

Treatment Option for Seasonal Affective Disorder

Factitious Anemia and Magnetic Resonance Imaging Abnormalities

Pregnancy and Respiratory Nocturnal Panic Attacks

Letters to the Editor

Treatment Option for Seasonal Affective Disorder

Dear Editor:

The following presentation revisits the diagnosis and successful treatment of major depressive disorder (MDE) with seasonal pattern.

Case Report

Mr KC, a 29-year-old African-American married man, has a 6-year history of apathy, low energy, anhedonia, sadness, hopelessness, insomnia, and increase in joint pain, leading to impairment in his performance of military duties, as well as in his relationship with his wife. Onset of symptoms occurred yearly, beginning in the fall and remitting in the spring. A detailed history revealed no symptoms of mania, psychosis, or anxiety. He has no history of alcohol and drug use. A family history revealed a biological mother suffering from major depression and a biological father suffering with alcoholism. Other than knee-joint pain, the patient has good physical health. He has been employed with the military for over 10 years. He presented to his physician at a military base with these symptoms and was diagnosed with major depression with seasonal pattern. Phototherapy treatment was unavailable at the military base. Further, because of duty shifts, it could not be offered as an option. A review of antidepressants provided evidence of a trial of selective serotonin reuptake inhibitors (SSRIs). Thus, a trial of citalopram 20 mg daily was initiated. At 2 and 4 weeks follow-up, Mr KC reported an increase in his energy level, an upbeat feeling, an improvement in mood, a restoration of normal sleep, and a significant decrease in knee-joint pain. His wife provided collateral information confirming this improvement. He started using less nonsteroidal antiinflammatory drug (NSAID) medication for pain and could return to some athletic activities, which he could not tolerate earlier.


The DSM-IV states that the regular temporal relation between the onset of major depression in fall or winter and its full remission in spring characterizes seasonal patterns. In Alaska, a study estimated a prevalence of 9.2% for seasonal affective disorder (SAD) (1). Light therapy has been the treatment of choice, with minimal side effects. Headache, eyestrain, and harmful effects on the retina are, however, potential side effects (2). Data for the pharmacologic treatment of SAD are rather limited. In controlled trials, however, fluoxetine and propranolol have been effective. Open trials have also shown positive results with bupropion and monoamine oxidase inhibitors (3,4). One National Institute of Mental Health group has studied response to the serotonergic agent, m-cpp, in SAD patients, suggesting that serotonin dysregulation is an area for further study. One case study suggested that citalopram, an SSRI, was as effective as phototherapy for SAD. Because the neurobiology and the diagnostic validity of SAD is not always obvious, good history taking and a trial of antidepressants, such as citalopram, may prove to be an effective treatment option alone (5,6).

One major question that remains to be studied is whether patients with SAD should be weaned off antidepressants in the spring. If successful weaning off occurs, the same antidepressant medication may be as effective for the next likely episode.


1. Wehr TA, Rosenthal NE. Seasonality and affective illness. Am J Psychiatry 1989;146:829–39.

2. Tam EM, Lam RW, Levitte AJ. Treatment of seasonal affective disorder: a review. Can J Psychiatry 1995;40:457–66.

3. Partonen T, Lonnqvist J. Moclodemide and Prozac in a treatment of SAD. J Affect Disord 1996;25:93–9.

4. Dilsaver SC, Etal. Efficacy of bupropion in winter depression: an open trial. J Clin Psychiatry 1992;53:252–5.

5. Joseph-Vanderpol J R, and others. Seasonal variation in behavior responses to m-cpp in patients with SAD and controls. Biol Psychiatry 1993;33:496–504.

6. Wirz-Justice Etal. Comparison of light treatment with citalopram in winter depression. Int Clin Psychopharmacol 1992;7:109–16.

James L Sullivan, MD
Isha Dewan, Science Student
Omaha, Nebraska

CJP Archives in English | Archives RCP en français
Supplements and Position Paper Inserts |
Lignes directrices cliniques, énoncés de principe et communiqués
Author Index to 2002 | Index RCP des auteurs 2002
Subject Index to 2002 | Index RCP des sujets 2002
Information for Contributors | Information à l'intention des auteurs
Style Notes for Contributors
Subscription Rates | Prix d'abonnements
Advertising Rates | Tarifs publicitaires
CPA Home | Page d'accueil